Microbiology & Infectious Diseases

Vitamin D deficiency remains significantly associated with worse clinical outcomes in patients with COVID-19, even in the post-Omicron era, according to new findings from a large-scale retrospective cohort study.

Metformin use linked to significantly lower colorectal cancer risk in patients with inflammatory bowel disease, according to a new population-based cohort study.

A single fecal microbiota transplant (FMT) may offer a safe and effective alternative for treating recurrent urinary tract infections (rUTIs), according to a new proof-of-concept study in postmenopausal women.

Orthopedic device infections in children present a unique clinical challenge, with distinct differences from adult cases in both patient characteristics and treatment requirements, according to a newly published review.

The sudden discontinuation of quinidine, the only FDA-approved treatment for severe malaria in the U.S. in 2017, raises urgent ethical concerns about the responsibilities of pharmaceutical companies and the healthcare system’s capacity to protect patient care.

Syphilis rates remain alarmingly high among people living with HIV in Türkiye, particularly in younger men, according to a new large-scale cross-sectional study analyzing national laboratory data.

Climate change is accelerating the emergence and spread of dangerous fungal infections, expanding their range and resistance in ways that could reshape global public health.

The gut microbiome may hold untapped potential in managing pain related to orthopaedic conditions, according to a new integrative review that highlights its emerging role in modulating inflammation and neurological pathways.